XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Oct. 03, 2025
Sep. 27, 2024
Oct. 03, 2025
Sep. 27, 2024
Revenues:        
Total revenues $ 597,755 $ 539,542 $ 1,721,463 $ 1,601,946
Operating expenses:        
Cost of goods sold 18,574 17,328 57,216 56,251
Research and development 199,164 222,570 611,753 661,406
Selling, general and administrative 123,661 111,801 395,703 357,800
Impairment of long-lived assets 0 51,672 0 51,672
Restructuring 19,816 96 19,816 33,406
Total operating expenses 361,215 403,467 1,084,488 1,160,535
Income from operations 236,540 136,075 636,975 441,411
Interest income 15,922 18,709 51,787 55,861
Other expenses, net (49) (29) (244) (405)
Income before income taxes 252,413 154,755 688,518 496,867
Provision for income taxes 58,835 36,782 150,476 115,461
Net income $ 193,578 $ 117,973 $ 538,042 $ 381,406
Net income per share:        
Basic (in dollars per share) $ 0.72 $ 0.41 $ 1.97 $ 1.31
Diluted (in dollars per share) $ 0.69 $ 0.40 $ 1.90 $ 1.28
Weighted-average common shares outstanding:        
Basic (in shares) 268,421 285,622 273,269 291,865
Diluted (in shares) 278,535 291,478 283,701 296,994
Net product revenues        
Revenues:        
Total revenues $ 542,930 $ 478,059 $ 1,576,227 $ 1,294,163
Collaboration revenues        
Revenues:        
Total revenues $ 54,825 $ 61,483 $ 145,236 $ 307,783